Integration of technology into clinical practice

Clinics in Laboratory Medicine

Volumn 33, Issue 3, 2013, Pages 705-729

  Doern, Christopher D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Clinical outcome(s); Decision support; Electronic medical record; Immunocompromised; MALDI TOF MS; Polymerase chain reaction; Respiratory virus panel; Walk away PCR

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACCESS TO INFORMATION; ANTIBIOTIC SENSITIVITY; AUTOMATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE; COMPUTER SYSTEM; DECISION SUPPORT SYSTEM; DIAGNOSTIC TEST; DISK DIFFUSION; ELECTRONIC MEDICAL RECORD; FECES ANALYSIS; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GASTROENTERITIS; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; INTERNET; INTERPERSONAL COMMUNICATION; LABORATORY AUTOMATION; LABORATORY TEST; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL DECISION MAKING; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; TECHNOLOGY; VIRUS IDENTIFICATION; CLASSIFICATION; COMMUNICABLE DISEASES; FUNGUS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; PROCEDURES; RESPIRATORY TRACT DISEASES; TRENDS; VIROLOGY; CLINICAL OUTCOME(S); COMMUNICABLE DISEASE; IMMUNOCOMPROMISED; MALDI-TOF MS; METHODOLOGY; RESPIRATORY TRACT DISEASE; RESPIRATORY VIRUS PANEL; WALK AWAY PCR;

BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; COMMUNICABLE DISEASES; DECISION SUPPORT TECHNIQUES; DISEASE NOTIFICATION; ELECTRONIC HEALTH RECORDS; FUNGI; HUMANS; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CLINICAL OUTCOME(S); DECISION SUPPORT; ELECTRONIC MEDICAL RECORD; IMMUNOCOMPROMISED; MALDI-TOF MS; POLYMERASE CHAIN REACTION; RESPIRATORY VIRUS PANEL; WALK AWAY PCR;

EID: 84881487051     PISSN: 02722712     EISSN: 15579832     Source Type: Journal    
DOI: 10.1016/j.cll.2013.03.004     Document Type: Review

References (78)

1. Doern G.V., Scott D.R., Rashad A.L. Clinical impact of rapid antimicrobial susceptibility testing of blood culture isolates. Antimicrob Agents Chemother 1982, 21(6):1023-1024.
2. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
3. Weinstein M.P., Murphy J.R., Reller L.B., et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983, 5(1):54-70.
4. Beekmann S.E., Diekema D.J., Chapin K.C., et al. Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges. JClin Microbiol 2003, 41(7):3119-3125.
5. Trenholme G.M., Kaplan R.L., Karakusis P.H., et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. JClin Microbiol 1989, 27(6):1342-1345.
6. Doern G.V., Vautour R., Gaudet M., et al. Clinical impact of rapid invitro susceptibility testing and bacterial identification. JClin Microbiol 1994, 32(7):1757-1762.
7. Barenfanger J., Drake C., Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. JClin Microbiol 1999, 37(5):1415-1418.
8. Kerremans J.J., Verboom P., Stijnen T., et al. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. JAntimicrob Chemother 2008, 61(2):428-435.
9. Bruins M., Oord H., Bloembergen P., et al. Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis 2005, 24(5):305-313.
10. Spencer D.H., Sellenriek P., Burnham C.A. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting. Am J Clin Pathol 2011, 136(5):690-694.
11. Blaschke A.J., Heyrend C., Byington C.L., et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 2012, 74(4):349-355.
12. Harris D.M., Hata D.J. Rapid identification of bacteria and candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Ann Clin Microbiol Antimicrob 2013, 12(1):2.
13. Hensley D.M., Tapia R., Encina Y. An evaluation of the advandx Staphylococcus aureus/CNS PNA FISH assay. Clin Lab Sci 2009, 22(1):30-33.
14. Bauer K.A., West J.E., Balada-Llasat J.M., et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 2010, 51(9):1074-1080.
15. Forrest G.N., Mehta S., Weekes E., et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. JAntimicrob Chemother 2006, 58(1):154-158.
16. Forrest G.N., Mankes K., Jabra-Rizk M.A., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. JClin Microbiol 2006, 44(9):3381-3383.
17. Forrest G.N., Roghmann M.C., Toombs L.S., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 2008, 52(10):3558-3563.
18. Bizzini A., Greub G. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification. Clin Microbiol Infect 2010, 16(11):1614-1619.
19. Cherkaoui A., Emonet S., Fernandez J., et al. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. JClin Microbiol 2010, 48(4):1169-1175.
20. Desai A.P., Stanley T., Atuan M., et al. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients. JClin Pathol 2012, 65(9):835-838.
21. Tan K.E., Ellis B.C., Lee R., et al. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. JClin Microbiol 2012, 50(10):3301-3308.
22. Mulet M., Lalucat J., Garcia-Valdes E. DNA sequence-based analysis of the Pseudomonas species. Environ Microbiol 2010, 12(6):1513-1530.
23. Brenner D.J., Grimont P.A., Steigerwalt A.G., et al. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies. Int J Syst Bacteriol 1993, 43(4):645-658.
24. Lambiase A., Del Pezzo M., Cerbone D., et al. Rapid identification of Burkholderia cepacia complex species recovered from cystic fibrosis patients using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. JMicrobiol Methods 2012, 92(2):145-149.
25. Choi S.H., Lee J.E., Park S.J., et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 2008, 52(3):995-1000.
26. Kaye K.S., Cosgrove S., Harris A., et al. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 2001, 45(9):2628-2630.
27. Seng P., Drancourt M., Gouriet F., et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49(4):543-551.
28. Ferroni A., Suarez S., Beretti J.L., et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. JClin Microbiol 2010, 48(5):1542-1548.
29. Fothergill A., Kasinathan V., Hyman J., et al. Rapid identification of bacteria and yeasts from positive BacT/ALERT blood culture bottles by using a lysis-filtration method and MALDI-TOF Mass Spectrum Analysis with SARAMIS Database. JClin Microbiol 2013, 51:805-809.
30. Kok J., Thomas L.C., Olma T., et al. Identification of bacteria in blood culture broths using matrix-assisted laser desorption-ionization Sepsityper and time of flight mass spectrometry. PLoS One 2011, 6(8):e23285.
31. Loonen A.J., Jansz A.R., Stalpers J., et al. An evaluation of three processing methods and the effect of reduced culture times for faster direct identification of pathogens from BacT/ALERT blood cultures by MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 2012, 31(7):1575-1583.
32. Romero-Gomez M.P., Gomez-Gil R., Pano-Pardo J.R., et al. Identification and susceptibility testing of microorganism by direct inoculation from positive blood culture bottles by combining MALDI-TOF and Vitek-2 Compact is rapid and effective. JInfect 2012, 65(6):513-520.
33. Schmidt V., Jarosch A., Marz P., et al. Rapid identification of bacteria in positive blood culture by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis 2012, 31(3):311-317.
34. Munson E.L., Diekema D.J., Beekmann S.E., et al. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. JClin Microbiol 2003, 41(1):495-497.
35. Clerc O., Prod'hom G., Vogne C., et al. Impact of Matrix-Assisted Laser Desorption Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF) on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis 2013, [Epub ahead of print].
36. Perez K.K., Olsen R.J., Musick W.L., et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2012, [Epub ahead of print].
37. Gander R.M., Byrd L., DeCrescenzo M., et al. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. JClin Microbiol 2009, 47(4):1021-1024.
38. Meex C., Neuville F., Descy J., et al. Direct identification of bacteria from BacT/ALERT anaerobic positive blood cultures by MALDI-TOF MS: MALDI Sepsityper kit versus an in-house saponin method for bacterial extraction. JMed Microbiol 2012, 61(Pt 11):1511-1516.
39. MacMillan D., Lewandrowski E., Lewandrowski K. An analysis of reference laboratory (send out) testing: an 8-year experience in a large academic medical center. Clin Leadersh Manag Rev 2004, 18(4):216-219.
40. Clark BC, Lewinski MA, Loeffelholz MJ, etal. Verification and validation of procedures in the clinical microbiology laboratory. Cumitech 31A. Herndon, VA: ASM Press; 2009.
41. Hayden R.T., Yan X., Wick M.T., et al. Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis. JClin Microbiol 2012, 50(2):337-345.
42. de Pagter P.J., Schuurman R., de Vos N.M., et al. Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. JClin Microbiol 2010, 48(7):2536-2540.
43. Hirsch H.H., Lautenschlager I., Pinsky B.A., et al. An international multicenter performance analysis of cytomegalovirus load tests. Clin Infect Dis 2013, 56(3):367-373.
44. Green M., Webber S.A. EBV viral load monitoring: unanswered questions. Am J Transplant 2002, 2(10):894-895.
45. Zimmermann H., Oschlies I., Fink S., et al. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry. Transplantation 2012, 93(5):543-550.
46. Sousa H., Silva J., Azevedo L., et al. Epstein-Barr virus in healthy individuals from Portugal. Acta Med Port 2011, 24(5):707-712.
47. Vouloumanou E.K., Rafailidis P.I., Falagas M.E. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol 2012, 19(1):14-20.
48. Barenfanger J., Drake C., Leon N., et al. Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study. JClin Microbiol 2000, 38(8):2824-2828.
49. Mahony J.B., Blackhouse G., Babwah J., et al. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections. JClin Microbiol 2009, 47(9):2812-2817.
50. Banerji A., Greenberg D., White L.F., et al. Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children: a case-control study. Pediatr Infect Dis J 2009, 28(8):697-701.
51. Wishaupt J.O., Russcher A., Smeets L.C., et al. Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial. Pediatrics 2011, 128(5):e1113-e1120.
52. Huijskens E.G., Biesmans R.C., Buiting A.G., et al. Diagnostic value of respiratory virus detection in symptomatic children using real-time PCR. Virol J 2012, 9:276.
53. Doan Q., Enarson P., Kissoon N., et al. Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department. Cochrane Database Syst Rev 2012, (5). CD006452.
54. Bonner A.B., Monroe K.W., Talley L.I., et al. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003, 112(2):363-367.
55. Doan Q.H., Kissoon N., Dobson S., et al. Arandomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an emergency department with febrile respiratory tract illnesses. JPediatr 2009, 154(1):91-95.
56. El Saleeby C.M., Somes G.W., DeVincenzo J.P., et al. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age. Pediatrics 2008, 121(2):235-243.
57. Jangi S., Lamont J.T. Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. JPediatr Gastroenterol Nutr 2010, 51(1):2-7.
58. Sunenshine R.H., McDonald L.C. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006, 73(2):187-197.
59. Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001, 7(8):405-410.
60. Katz D.A., Lynch M.E., Littenberg B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 1996, 100(5):487-495.
61. Sidler J.A., Haberthur C., Heininger U. Aretrospective analysis of nosocomial viral gastrointestinal and respiratory tract infections. Pediatr Infect Dis J 2012, 31(12):1233-1238.
62. Beersma M.F., Sukhrie F.H., Bogerman J., et al. Unrecognized norovirus infections in health care institutions and their clinical impact. JClin Microbiol 2012, 50(9):3040-3045.
63. Zhang G., Hu Y., Wang H., et al. High incidence of multiple viral infections identified in upper respiratory tract infected children under three years of age in Shanghai, China. PLoS One 2012, 7(9):e44568.
64. De Schutter I., De Wachter E., Crokaert F., et al. Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin Infect Dis 2011, 52(12):1437-1444.
65. Bresee J.S., Marcus R., Venezia R.A., et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. JInfect Dis 2012, 205(9):1374-1381.
66. Bruins M.J., Ruijs G.J., Wolfhagen M.J., et al. Does electronic clinical microbiology results reporting influence medical decision making: a pre- and post-interview study of medical specialists. BMC Med Inform Decis Mak 2011, 11:19.
67. Ferris T.G., Johnson S.A., Co J.P., et al. Electronic results management in pediatric ambulatory care: qualitative assessment. Pediatrics 2009, 123(Suppl 2):S85-S91.
68. Callen J.L., Westbrook J.I., Georgiou A., et al. Failure to follow-up test results for ambulatory patients: a systematic review. JGen Intern Med 2012, 27(10):1334-1348.
69. Kilpatrick E.S., Holding S. Use of computer terminals on wards to access emergency test results: a retrospective audit. BMJ 2001, 322(7294):1101-1103.
70. Kuperman G.J., Teich J.M., Tanasijevic M.J., et al. Improving response to critical laboratory results with automation: results of a randomized controlled trial. JAm Med Inform Assoc 1999, 6(6):512-522.
71. Coupat C., Pradier C., Degand N., et al. Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study. Eur J Clin Microbiol Infect Dis 2012, [Epub ahead of print].
72. Gonzales R., Anderer T., McCulloch C.E., et al. Acluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med 2013, 1-7.
73. Litvin C.B., Ornstein S.M., Wessell A.M., et al. Use of an electronic health record clinical decision support tool to improve antibiotic prescribing for acute respiratory infections: the ABX-TRIP Study. JGen Intern Med 2012, [Epub ahead of print].
74. Patel J., Esterly J.S., Scheetz M.H., et al. Effective use of a clinical decision-support system to advance antimicrobial stewardship. Am J Health Syst Pharm 2012, 69(18):1543-1544.
75. Mainous A.G., Lambourne C.A., Nietert P.J. Impact of a clinical decision support system on antibiotic prescribing for acute respiratory infections in primary care: quasi-experimental trial. JAm Med Inform Assoc 2013, 20:317-324.
76. Litvin C.B., Ornstein S.M., Wessell A.M., et al. Adoption of a clinical decision support system to promote judicious use of antibiotics for acute respiratory infections in primary care. Int J Med Inform 2012, 81(8):521-526.
77. Charani E., Kyratsis Y., Lawson W., et al. An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt. JAntimicrob Chemother 2013, 68:960-967.
78. Rothman B., Leonard J.C., Vigoda M.M. Future of electronic health records: implications for decision support. Mt Sinai J Med 2012, 79(6):757-768.